Response to Press Speculation

In response to the recent press speculation regarding Advanced Medical Solutions Group plc (the "Company" or "AMS"), Montagu Private Equity LLP, in its capacity as adviser to funds managed and/or advised by it or its affiliates ("Montagu"), confirms that it is considering a possible offer for the Company.

There can be no certainty that any firm offer will be made and a further announcement will be made as and when appropriate.

Any offer, if made, is likely to be solely in cash, although Montagu reserves the right to vary the form of consideration and/or introduce other forms of consideration.

In accordance with Rule 2.6(a) of the Code, Montagu must, by not later than 5.00 pm (London time) on 24 April 2025, either announce a firm intention to make an offer for the Company in accordance with Rule 2.7 of the Code or announce that it does not intend to make an offer, in which case the announcement will be treated as a statement to which Rule 2.8 of the Code applies. This deadline will only be extended with the consent of the Takeover Panel in accordance with Rule 2.6(c) of the Code.

Disclosure Requirements

Rule 2.4 Information

In accordance with Rule 2.4(c)(iii) of the Code, Montagu confirms that it is not aware of any dealings in AMS shares that would require it to offer a minimum level, or a particular form, of consideration under Rule 6 or Rule 11 of the Code. However, it has not been practicable for Montagu to make enquiries of all persons acting in concert with it prior to the date of this announcement in order to confirm whether any details are required to be disclosed under Rule 2.4(c)(iii) of the Code. To the extent that any such details are identified following such enquiries, Montagu shall make an announcement disclosing such details as soon as practicable, and in any event by no later than the time it is required to make its Opening Position Disclosure under Rule 8.1 of the Code.

Rule 26.1 Disclosure